TNF/cachectin constitutes one of the major inflammatory mediators secreted by activated monocytes and macrophages (I); it is implicated as a primary and proximal mediator ofendotoxic shock (2) and plays a physiologic role in inflammation. Receptors for the Fe domain of immunoglobulins are involved in the regulation of various monocyte/macrophage immune functions, including phagocytosis (3), antibody-dependent cell-mediated cytotoxicity (4), the clearance of immune complexes (5), and the secretion of inflammatory mediators (6). Among the secretory products induced by Fe interactions are leukotrienes (7), prostaglandins (8), various hydrolytic enzymes (9), and multiple cytokines, including IL-I (10), IL-6 (II), and TNF (12). Debets et al. (12) showed that when monocyte Fe receptors bound with cytophilic human IgG were cross-linked by the addition of antihuman IgG, rapid secretion of TNF was induced. These experiments were conducted with adherent adult human monocytes; soluble IgG alone failed to induce a response. In subsequent work, Debets et al. (13) demonstrated that cross-linking of FcR was not sufficient for the induction ofTNF but that high affinity Fc-FcR interactions are required. Kuhnert et al. (14) demonstrated the induction of TNF and IL-I secretion by adult human mononuclear cells cultured in suspension in the presence of soluble IgG and 10% autologous serum. Moreover, suspension cultures of mononuclear cells exposed to IgG were primed for enhanced production of TNF and IL-I upon subsequent stimulation with LPS. Although F(ab')2 fragments exhibited priming capacity similar to intact IgG, they were unable to induce cytokine secretion by themselves, again suggesting that the Fe portion of IgG is important in inducing a cytokine response.
TNF/cachectin constitutes one of the major inflammatory mediators secreted by activated monocytes and macrophages (I); it is implicated as a primary and proximal mediator ofendotoxic shock (2) and plays a physiologic role in inflammation. Receptors for the Fe domain of immunoglobulins are involved in the regulation of various monocyte/macrophage immune functions, including phagocytosis (3), antibody-dependent cell-mediated cytotoxicity (4), the clearance of immune complexes (5) , and the secretion of inflammatory mediators (6) . Among the secretory products induced by Fe interactions are leukotrienes (7), prostaglandins (8) , various hydrolytic enzymes (9) , and multiple cytokines, including IL-I (10), IL-6 (II), and TNF (12) . Debets et al. (12) showed that when monocyte Fe receptors bound with cytophilic human IgG were cross-linked by the addition of antihuman IgG, rapid secretion of TNF was induced. These experiments were conducted with adherent adult human monocytes; soluble IgG alone failed to induce a response. In subsequent work, Debets et al. (13) demonstrated that cross-linking of FcR was not sufficient for the induction ofTNF but that high affinity Fc-FcR interactions are required.
Kuhnert et al. (14) demonstrated the induction of TNF and IL-I secretion by adult human mononuclear cells cultured in suspension in the presence of soluble IgG and 10% autologous serum. Moreover, suspension cultures of mononuclear cells exposed to IgG were primed for enhanced production of TNF and IL-I upon subsequent stimulation with LPS. Although F(ab')2 fragments exhibited priming capacity similar to intact IgG, they were unable to induce cytokine secretion by themselves, again suggesting that the Fe portion of IgG is important in inducing a cytokine response.
Multiple clinical trials have evaluated IVIG as adjunctive therapy for neonatal sepsis (15) (16) (17) (18) (19) , and although the results suggest benefit, the small numbers of patients studied prevent any conclusions regarding efficacy. IVIG is also being investigated for the prophylaxis of neonatal sepsis (20) (21) (22) (23) (24) (25) (26) . These studies have not revealed any significant toxic effects associated with IVIG administration. Because of the potential for IgG-FcR interactions to occur in vivo when IVIG is administered, we sought to examine the in vitro effects of IVIG on neonatal MO TNF production. Studies have shown that neonatal monocytes are as competent as adult monocytes in the processing and presentation of antigen (27) and phagocytosis and killing of bacteria (28) . However, certain functions are diminished compared with adults, such as chemotaxis (29, 30) and antibodydependent cellular cytotoxicity to herpes simplex virus (31) . Kohl et al. (31) found decreased expression of the high-affinity IgG FcR expression may partly explain low neonatal mononuclear cell antibody-dependent cellular cytotoxicity. To determine whether the regulatory effects of IVIG regarding MO TNF production are specific to neonates, we paralleled select experiments in adult MO. In initial experiments, we examined the ability of soluble human IgG, in the form of IVIG, to induce TNF production. We then investigated the immunomodulating effects of IVIG by examining its effect on the MO TNF response induced by the known stimulants IFN-'Y and LPS.
MATERIALS AND METHODS
Cell isolation and culture. Blood samples were obtained from the umbilical cords of normal , full-term, nonstressed neonates by using sterile blood collection tubes containing dry Na2-EDTA or from healthy adult volunteers by using sterile heparinized syringes (10) U heparin/L blood). After collection, the blood was diluted I: I with sterile PBS. The cell suspension was overlaid on Histopaque 1077 (Sigma Chemical Co., St. Louis, MO) and the mononuclear cells were separated by density-gradient centrifugation. These cells were washed once with sterile PBS and then incubated for 10 min at 37'C in O.oI M Tris-0.83% NH4C1 (pH 7.2-7.4) to lyse contaminating red blood cells. After centrifugation, cells were washed twice more with sterile PBS before they were resuspended in RPMI 1640 (GIBCO, Grand Island, NY) containing 2 mM i. 10-3 M (0.1 giL, or I gil). All IgG fragments were obtained from Jackson ImmunoResearch Laboratories, West Grove, PA. Monolayers were incubated for 2,6, or 24 h at 37"C in 5% CO2. In early experiments, 50 or 100 gil of IgG were also used. Monolayer cell counts revealed that such high concentrations of IgG induced significant cell loss (85-95% compared with 40-75% loss of cells incubated in lower concentrations ofIgG). After incubation, the plates were centrifuged at 300 x g for 5 min and the cell-free supernatants were harvested from each well. Supernatants from each of three wells that had been treated the same were pooled and stored at -70'C until used for the TNF assays.
In a second series of experiments, monolayers were treated as above; after this initial incubation in medium or medium with IgG or IgG fragments, supernatants were removed, and 0.25 mL of either culture medium or culture medium with lOS U/L (100 U/mL) of human IFN-'Y (Genzyme Corp., Cambridge, MA) and I mg/L (I~g/mL) of Escherichia coli LPS (Sigma) were added to each well. After 3 h of incubation at 37'C in 5% CO 2 , plates were centrifuged at 300 x g for 5 min, and the cell-free supernatants were harvested and stored at -70'C until used for the TNF assays. Additional experiments performed in this series at 37'C in 5% CO 2 , plates were centrifuged at 300 x g for 5 min, and the cell-freesupernatants were harvested and stored at -70'C until analyzed for TNF by ELISA.
In a final series of experiments, monolayers were incubated in IFN-'Y (lOs U/L)/LPS (I mg/L) overnight (18 h), and after centrifugation, the cell-free supernatants were harvested for TNF assays. These cells were then replated with media alone or media with IgG in a concentration of 10 gil and incubated for 6 h at 37"C in 5% CO 2. After incubation, supernatants were harvested and stored at -70'C until analyzed for TNF by ELISA.
Cell counts were made of each group using the pronasecetrimide procedure for counting cell nuclei (32) . Briefly, to count cells, 0.5 mL of freshly filtered dilute pronase (Sigma) was equally divided among the three wells of a group, mixed, and allowed to incubate for 15 min at 37·C. After this incubation, the pronase suspension was pulled from the wells and put into 12.5 mL of filtered cetrimide (Sigma) solution in an Accuvette II vial (Coulter, Hialeah, FL). The suspension of cell nuclei was then promptly counted in an electronic particle counter (Coulter).
TNF bioassay. TNF activity was determined by using an adaptation of the lytic assay of Carswell et al. (33) as modified by Aggarwal et al. (34) . Briefly, mouse L929 fibroblast cells were plated in 96-well plates at a concentration of 4 x 10 4 cells/well. After an overnight incubation, supernatants were added to the plates and serially diluted in horizontal rows. To determine the specificity of the assay, appropriate dilutions of selected supernatants or standard human recombinant TNF (sp act 5 x 10 7 U/mg) (Genenteeh, South San Francisco, CA) were preincubated with 5 neutralizing U of TNF MAb (sp act 6 x 10 6 neutralizing U'/mg) (Genentech) for 4 h at 4'C before addition to the plates. Actinomycin 0 (8 mg/L) (Sigma) was added to each well and plates were incubated overnight. After overnight incubation, samples were removed and plates washed with warm PBS to remove dead cells. The plates were stained with 0.05% crystal violet in 20% ethanol for 10 min . Plates were then washed with cold tap water and allowed to dry for 24 h. After drying, stain was eluted with I00~L of 100% methanol per well. Plates were read within 10 min of methanol addition at 562 nm on a microplate reader. 00 of L929 cells incubated with medium alone represented 0% lysis, and cells treated with 3 M guanidine hydrochloride represented 100% lysis. One unit of TNF is defined as that amount of TNF required to produce 50% lysis. Lysiswas normalized to a standard of human recombinant TNF. The lower limit of detectability was 50 ng/L (2.5 U/ml.), TNF-ELISA. TNF concentrations of cell-free supernatants were determined with a TNF-specific ELISA kit (Genzyme) according to the manufacturer's instructions. The lower limit of detectability for this assay is 10 ng/L, RNA isolation and Northern blot analysis. At the indicated times, total cellular RNA was isolated by the guanidium isothiocyanate-CsCI method (35) . Total RNA samples were electrophoresed in 1.2% agarose/formaldehyde gels, and the integrity of the RNA was confirmed by ethidium bromide staining. ing its effect on the MO TNF response induced by IFN--y/LPS. Preincubation of CBMO in I, 10, or 25 giL IgG for 2 or 6 h caused enhanced secretion ofTNF upon subsequent stimulation (Table 2) . Despite the considerable subject-to-subject variation, the trend for enhancement was consistent. A 6-h preincubation with 25 g/L IgG resulted in the greatest enhancement of TNF secretion (-5-fold, compared with a 3-fold increase at 2 hand only a 2-fold increase when monolayers were preincubated with IgG for 24 h). This deciine in enhancement with the 24-h preincubation was not caused by increased cell loss; cell loss varied from 40 to 75% for all three preincubation times as determined by monolayer cell counts. In addition, the time of preincubation did not significantly alter the TNF secretion detected in those cells pretreated with medium alone, in which cell loss also varied between 40 and 75%.ln preliminary experiments, concentrations of 50 g/L IgG and greater led to a marked decrease in TNF secretion, yet this concentration resulted in >80% cell loss. Therefore, 25 g/L IgG became the maximum concentration used in our experiments.
Preincubation of adult MO with IgG for 6 h before stimulation with IFN--yILPS also resulted in enhanced secretion of TNF (Table 2) . Compared with CBMO, adult MO preincubated in medium alone produced significantly greater amounts of TNF upon stimulation with IFN--y/LPS (3353.2 ± 2946.7 versus 1215.0 ± 575.9 ng/L), Therefore, the relative increase in TNF production by adult MO preincubated with IgG was less than that of CBMO (-2-fold increase in adult MO, compared with -5-fold increase in CBMO). Concentrations of 10 and 25 giL IgG were able to induce CBMO to secrete levels of TNF approaching those detected with adult MO (4070. 4 Results of an L929 cytotoxicity assay on supernatants from CBMO preincubated for 2 and 6 h with IgG (1-25 g/L) confirmed the enhancement of TNF secretion and indicated that the TNF was functional (Table 3) . Once again, preincubation with 25 g/L IgG for 6 h resulted in the greatest secretion ofTNF upon subsequent stimulation with IFN--y/LPS.
To explore the dose-response paradigm more completely, we performed experiments with CBMO using the lower concentrations of 6.3 x 10-8 M (0.0 I giL) and 6.3 x 10-7 M (0.1 giL) IgG for preincubation. Preincubation in these lower concentrations of IgG for 2 or 6 h did not enhance the TNF response seen upon subsequent stimulation with IFN--y/LPS (Table 3) . Thus, the ability of IgG to enhance IFN--yILPS-induced TNF secretion by MO in vitro is dose dependent with a threshold concentration [6.3 x 10-6 M (I giL)) below which an enhanced response is not induced.
Northern analyses were performed on MO treated in the same manner to determine at what molecular level the TNF response was being increased. Depicted in Figure 2 is 
RESULTS

Evaluation of TNF response in adherent MO exposedto IgG.
Adherent CBMO were exposed to increasing concentrations of IgG, and at specific time intervals (2, 6, and 24 h) supernatants were harvested and examined by ELISA for TNF. As shown in Table I , incubation in concentrations ofIgG from 6.3 x 10-6 M to 1.6 X 10-4 M (1-25 g/L) for 6 h did not induce secretion of TNF more than adherence alone. Although low levels of TNF were detected in the supernatants of some of the cultures, the majority had levels that were barely detectable. Comparable results were seen in monolayers incubated for 2 and 24 h (data not shown).
Northern blot analysis of MO RNA levels paralleled these results. Depicted in Figure I IgG also had no effect (data not shown). These data indicate that soluble IgG alone does not induce significant production of TNF by adherent CBMO.
To determine whether a lack of response in our system was specific for neonatal MO, we analyzed supernatants from adult MO monolayers incubated with IgG. Again, we found that soluble IgG was unable to induce secretion of TNF greater than that caused by adherence (Table I) .
Effect ofIgG on MO IFN--yILPS-induced TNF response.
We investigated the immunomodulating effects of IVIG by examinIgG MODULATES MO TNF PRODUCTION IN VITRO sodium chloride, sodium citrate (SSC), I x Denhardt's, 50 mM sodium phosphate (pH 6.5), 0.1 % SDS, 0.250 giL salmon sperm DNA, and 10% dextran sulfate. Blots were hybridized for 18 h in the same buffer containing 10 6 cpm/rnl, of cDNA probe. The probes used were a human TNF cDNA fragment, the 800-bp EcoRI cDNA fragment (36) , and a 2-kb human fj-actin cDNA (Clontech, Palo Alto, CA) that were randomly labeled (Boehringer Mannheim Corp., Indianapolis, IN) overnight at 25·C; unincorporated nucieotides were removed by push column (Stratagene Cloning Systems, La Jolla, CA). After hybridization, blots were washed once with 2 x SSC, 0.1 % SDS for 30 min at 25·C, followed by two washes with 0.1 x SSC, 0.1 % SDS for 20 min at 55·C, and exposed to Kodak XAR-5 film at -70·C with intensifying screens. For RNA quantification, filters were dehybridized and then rehybridized with the fj-actin probe and exposed for 5 d. Stripping was confirmed in each case by autoradiography before a second probe was used. Multiple autoradiographic exposures of multiple blots were quantitated by scanning on a laser densitometer (Hoefer Scientific Instruments, San Francisco, CAl. Calculated ratios ofTNF to fj-actin mRNA levels were used for comparisons within groups.
Statistics. The two-sample t test for unpaired data was used for statistical analysis. Differences were considered significant at the two-tailed p < 0.05 level. Fig. 3, lane 1) . IFN-'Y/LPS stimulation led to greatly increased accumulations of TNF mRNA. Preincubation of CBMO in 25 giL IgG for 6 h increased the levels of TNF message induced by IFN-'YILPS by -2-fold (by densitometry). Northern analyses performed with adult MO yielded similar results ; increased levels of mRNA for TNF were detected only when the higher concentration of 25 gI L IgG was used for preincubation (data not shown) .
We performed an additional set of experiments to examine the ability of IgG to potentiate an IFN-'Y/LPS-induced TNF response. CBMO were incubated in IFN-'Y/LPS for 18 h, after which their supernatants were removed for TNF assay. A group of cells was replated in medium and a second group in 10 g/L IgG. After a 6-h incubation, supernatants were again harvested for analysis. TNF secretion as detected by ELISA was 641. 71 45.3 ng/L for cells incubated in IFN-'YILPS for 18 h. When the cells were replated in medium for 6 h, the amount of TNF detected decreased to 59.9 ± 34.6 ng/L, but in cells replated with 10 g/L ofIgG for 6 h, the levels ofTNF remained high (602.2 ± 243.7 ng/L), Values are means ± SO of 10 experiments each. Detection of TNF in the last group of cells indicates the ability of IgG to augment a prior stimulus for TNF release. Although these data support and confirm our earlier results, they do not increase our knowledge of the mechanism for this increased response. (Fig. 3) . TNF mRNA was detectable 
DISCUSSION
In previous works by Kuhnert et al. (14) , the addition of soluble IgG to human mononuclear cells in suspension induced the secretion of TNF and IL-1. In contrast, Debets et al. (12) , found that solid-phase antibodies specific for binding FC'YRI or FC'YRII induced TNF secretion by adherent human monocytes, whereas the same antibodies in the fluid phase failed to induce a response. An additional study by Shimozato et al. (37) demonstrated that i.v, infusion of IgG resulted in a reduction of TNF serum levels in rabbits subsequently given LPS and that IgG suppressed the production of TNF by rabbit macrophages stimulated in vitro with LPS.
Because of the widespread use of IVIG in our neonatal nur-
The potential exists for antibodies present in the IVIG to bind LPS, creating LPS/IgG immune complexes, which could act as a potent stimulus in vitro. We explored this possibility by adding IgG, IFN-'Y, and LPS simultaneously. CBMO were incubated for 3 h in the stimulants IFN-'Y and LPS or in IFN-'YILPS in combination with I, 10, or 25 g/L IgG. Although a trend toward increased TNF secretion was detected, the increases were not statistically significant ( (Table 4) . However, when CBMO were preincubated in 9.1 x 10-7 M (0.1 giL) or 9.1 x 10-6 M (I giL) F(ab'h fragments, enhanced TNF secretion was detected. Th is enhancement was not as great as that previously seen with whole IgG molecules (maximum increase seen was -3-fold) ( Table 4) . Experiments were also performed in which CBMO were incubated in these reagents without subsequent stimulation with IFN-'YILPS . Negligible amounts of TNF were induced by these reagents alone (data not shown).
series for both prophylaxis and treatment of sepsis, we initially sought to address the question of the ability of IgG to induce TNF production by neonatal MO. We demonstrated that the addition of soluble IgG to adherent CBMO is not a sufficient stimulus to generate the production of TNF (Table I, Fig. I ). This was true for adult MO as well; we demonstrated that the lack of response is not due to a deficiency inherent to the neonate. In addition , all experiments were performed in monocyte-derived macrophages that were cultured for 5 d. Time in culture allows for the development of FC'YRIII expression, in addition to the constitutive expression of FC'YRI and FC'YRII. FC'YRIII develops on monocytes in vitroafter 2 d of culture (38) , although recently it was discovered that a subpopulation (-10%) of freshly isolated monocytes expresses FC'YRIII (39) . Thus , in our system, the potential exists for IgG to interact with any or all three of the FC'YR. Kuhnert et al. (14) used 10% autologous serum in their experiments and proposed that dimeric IgG generated by idiotype-antiidiotype complexes between donor and host IgG or between IgG molecules from different donors are a possible mechanism whereby IVIG promotes cytokine synthesis. Our experiments used 10% pooled human AB serum and concentrations of IVIG that are comparable to those seen in vivo (22, 40) . The obvious difference between our experiments and those performed by Kuhnert et al. (14) is that we used MO cultured as adherent monolayers rather than as suspended cells. It is possible that the act of adherence inhibited the induction ofTNF by IgG. The prolonged contact ofmonocytes with polystyrene can inhibit other FcR-mediated functions, such as phagocytosis of opsonized erythrocytes (41) . Evidence against inhibition ofTNF production by adherence lies in the positive results of the studies of Debets et al. (12, 13) . Furthermore, we have previously shown that the act of adherence turns on various cytokine genes in MO, including the gene for TNF (42) . (Table 3) .
Northern analyses of mRNA for TNF indicated that the increased TNF response mediated by IgG primarily occurred posttranscriptionally (Fig. 2) . Although preincubation of MO in I and 10 g/L IgG resulted in significant increases in the secretion of TNF, levels of TNF mRNA were unchanged. These concen- in mRNA for TNF). This increase in mRNA for TNF could be caused by enhanced mRNA stability or by an increase in transcription. Data supporting a posttranscriptional mechanism for augmentation come from experiments in which CBMO were first incubated in the stimulants IFN-'Y/LPS for 18 h, then incubated in either medium alone or medium with to g/L IgG for 6 h. The addition of IgG allowed for continued detection of TNF (602.2 ± 243.7 ng/L), whereas in cells replated with medium alone the TNF levels were minimal (59.9 ± 34.6 ng/L). IFN-'Y combined with LPS, in the concentrations used in our study, has been shown to induce transcription of TNF mRNA at near maximal levels (44) . In addition, studies indicate that once the TNF gene is transcriptionally active posttranscriptional mechanisms operate to control TNF gene expression (45, 46) . Therefore, the ability ofigG to induce an enhanced response in the face of prior stirnulation with IFN-'Y/LPS suggeststhat the entire effect of IgG demonstrated in our study is most likely posttranscriptionally mediated.
Several mechanisms could be acting to produce this effect. The potential exists for antibodies present in the IVIG to bind to LPS and form IgG/LPS immune complexes that could act as a potent stimulus for TNF production in vitro. Interestingly, when CBMO were incubated in IgG and IFN-'Y/LPS simultaneously for 3 h, no significant increase in TNF secretion was detected compared with cells incubated in IFN-'Y/LPS alone. Thus, it seems unlikely that IgG/LPS complexes are the stimulus for enhanced TNF production in our studies. A 2-h preincubation in IgG before a 3-h incubation in IFN-'Y/LPS resulted in a significant increase in TNF secretion compared with CBMO preincubated in medium alone. These data indicate that a minimum amount of time must be present for IgG to interact with the MO and produce the signals necessary for an enhanced response.
To further explore the mechanism whereby IgG enhances IFN-' Y/LPS-induced TNF production, experiments were performed with the Fe, Fab, and Ftab'), fragments ofIgG. Only the F(ab')2 fragments were able to produce an enhanced response, which did not reach the levels seen with whole IgG molecules. These results indicate involvement of the Ftab'), portion of IgG. It should be noted that all our experiments were performed in 10% pooled human AB serum containing significant amounts of IgG. The results of our study also indicate a concentration dependence of this enhanced response, with 25 g/L IgG consistently producing the maximum increase in TNF secretion and no increase in TNF secretion being detected when concentrations of IgG below I g/L were used with CBMO.
Another potential mechanism is that exposure of MO to IFN-'Y leads to up-regulation of FC'YRI (47), which then binds IgG through its Fe region, leading to high levels of IgG-FcR interaction that stimulate pathways that augment the TNF response. However, this does not explain the positive effects of F(ab'h fragments.
Interaction of FC'YR with immune complexes has been shown to trigger release of a variety of soluble mediators. Debets et al. (13) demonstrated that MO FcR cross-linking was necessary but not sufficient for the induction of TNF by IgG; no response was seen with the use of anti-FcR MAb and bridging antibody. In our system, enumerable IgG idiotopes exist; IgG is present from host, from serum that is used for culture, and from more than to 000 donors in the IVIG. Perhaps the formation of idiotypeantiidiotype complexes between the multiple sources of IgG, or between the multiple sources ofigG and F(ab')2 fragments, leads to cross-linking of some FcR and binding of others through the Fe region of IgG. Higher concentrations ofIVIG would increase the chance for such processes to occur. These interactions are obviously not sufficient to stimulate TNF release by themselves but are able to augment stimulatory pathways. A fourth hypothesis is that a1loantibodies react with MO surface antigens, thereby promoting cell activation. IL-I is induced in human monocytes exposed to antibodies against Ia antigens (48) . Alloantibodies directed against immunoglobulin allotopes might also function to produce immune complex formation, thereby promoting cell stimulation. It is also possible that no single mechanism is responsible for the increase in TNF production, but that several different IgG-MO interactions combine to produce the observed response.
The absence of a TNF response by M0 cultured in the presence of IVIG in vitro lends support to the continued use of IVIG as replacement therapy for neonates, as well as for other patients with hypogammaglobulinemia. It has been proposed that the interaction of MO with IVIG dampens the cytokine response to other unrelated stimuli (49) . Indeed, IVIG has been shown to be clinically beneficial in patients with Kawasaki disease (40) and infection-associated hemophagocytic syndrome (50) , conditions associated with cytokine activation. In addition, multiple treatment studies in neonates with sepsis have not demonstrated any toxic effects associated with IVIG administration (15) (16) (17) (18) (19) . The enhanced TNF response detected from MO cultured in the presence of IgG and stimulated with IFN-'Y/LPS in vitro is not consistent with these in vivo observations. Several possibilities exist for this discrepancy. Our studies examined isolated populations of MO, whereas in vivo multiple inflammatory cells and their products interact in a complex manner to control cytokine production. It is also possible that IgG elicits different responses when interacting with blood monocytes in the peripheral circulation than when interacting with adherent macrophages in the tissues.
In at least two animal models of established infection, infusion ofigG in addition to antibiotics has been found to be detrimental, resulting in increased mortality rates (51, 52) . Both these studies used high doses ofiVIG in rats, indicating that deleterious effects may not be seen unless high in vivo concentrations of IgG are produced. These animal studies support the detection of a lower threshold concentration in our present in vitro studies. The immunomodulating effects of IVIG are complex and include Fe receptor blockade, antiidiotype effects, and possibly down-regulation of immunoglobulin synthesis. The data presented here are further indications of the complex network of responses that exist to control the inflammatory response.
